Q1 2025 · 13F-HR
Stonepine Capital Management, LLCholdings as filed
Filed 2025-05-14 · accession 0000935836-25-000328
$102.8M
Reported value
66
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30052C107 | EOLS | EVOLUS INC | $13.6M | 13.3% | 1,134,574 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $13.6M | 13.3% | 48,000 | Common | SOLE |
| 68404V209 | OPTNUSD | OPTINOSE INC | $7.2M | 7.04% | 788,647 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $4.9M | 4.74% | 650,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $3.7M | 3.60% | 613,000 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $3.7M | 3.59% | 333,400 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $3.3M | 3.24% | 285,782 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $3.3M | 3.17% | 590,742 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $3.3M | 3.17% | 206,639 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $3.0M | 2.96% | 74,500 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $3.0M | 2.96% | 200,000 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $2.9M | 2.82% | 304,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $2.8M | 2.69% | 527,842 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $2.8M | 2.69% | 348,820 | Common | SOLE |
| 98419J206 | XOMA | XOMA ROYALTY CORPORATION | $2.6M | 2.52% | 129,813 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $2.5M | 2.44% | 2,055,225 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $2.4M | 2.30% | 93,968 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $2.0M | 1.95% | 914,973 | Common | SOLE |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $1.8M | 1.70% | 796,100 | Common | SOLE |
| 27966L306 | EDSA | EDESA BIOTECH INC | $1.7M | 1.63% | 687,500 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $1.3M | 1.30% | 276,707 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.0M | 0.99% | 100,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $937,189 | 0.91% | 144,628 | Common | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $914,417 | 0.89% | 347,687 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $844,880 | 0.82% | 518,331 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MEDICAL CORP | $814,462 | 0.79% | 139,942 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $795,000 | 0.77% | 463,721 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $795,000 | 0.77% | 500,000 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $738,357 | 0.72% | 212,783 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $686,899 | 0.67% | 630,183 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $665,683 | 0.65% | 294,550 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $656,700 | 0.64% | 110,000 | Common | SOLE |
| 38942Q202 | CALC | CALCIMEDICA INC | $615,119 | 0.60% | 367,371 | Common | SOLE |
| 19459J104 | COLL | COLLEGIUM PHARMACEUTICAL INC | $615,119 | 0.60% | 20,607 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $603,947 | 0.59% | 200,647 | Common | SOLE |
| 984241109 | YMABUSD | Y-MABS THERAPEUTICS INC | $581,039 | 0.57% | 131,160 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $561,435 | 0.55% | 102,265 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $500,815 | 0.49% | 620,588 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $488,000 | 0.47% | 100,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $413,923 | 0.40% | 167,580 | Common | SOLE |
| 44975P103 | NBP | I MAB | $398,477 | 0.39% | 483,647 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $394,206 | 0.38% | 68,084 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $346,478 | 0.34% | 238,950 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $343,732 | 0.33% | 95,747 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $275,406 | 0.27% | 278,188 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $248,687 | 0.24% | 21,550 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $203,500 | 0.20% | 508,266 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $203,500 | 0.20% | 50,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $200,025 | 0.19% | 250,000 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $188,000 | 0.18% | 50,000 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $185,850 | 0.18% | 35,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $185,850 | 0.18% | 93,393 | Common | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $161,329 | 0.16% | 35,148 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $148,982 | 0.14% | 54,975 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $105,000 | 0.10% | 10,000 | Common | SOLE |
| 023111206 | — | AMARIN CORP PLC | $105,000 | 0.10% | 651,614 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS LLC | $95,400 | 0.09% | 60,000 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $83,122 | 0.08% | 46,698 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $80,549 | 0.08% | 29,079 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $66,600 | 0.06% | 20,000 | Common | SOLE |
| 88338H704 | TQ80 | THERATECHNOLOGIES INC | $36,155 | 0.04% | 25,825 | Common | SOLE |
| 29089Q105 | EBS | EMERGENT BIOSOLUTIONS INC | $24,300 | 0.02% | 5,000 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $24,300 | 0.02% | 810,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $18,400 | 0.02% | 10,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $14,400 | 0.01% | 10,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $14,400 | 0.01% | 102,242 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.